Literature DB >> 27717830

Duration of untreated illness as a key to early intervention in schizophrenia: A review.

Andrea Murru1, Bernardo Carpiniello2.   

Abstract

The first psychotic episode is classically viewed as a critical period which management is important in determining the long-term outcome of the schizophrenia (SCZ). For this reason, the duration of untreated illness (DUI), defined as the interval between the onset of the psychiatric disorder and the administration of the first pharmacological treatment, is a clinical variable that has been increasingly investigated due to its potentially modifiable nature and its value as a predictor of outcome. DUI is poorly applicable and highly unreliable in psychosis. The present critical review examines the impact of DUI and its more operative definition of "duration of untreated psychosis" (DUP) in the course and outcome of SCZ, focusing on its epidemiologic, clinical, prognostic factors. Length of DUP has been identified as positively related to a worst treatment response, symptom control and overall functional outcome in SCZ. Negative symptoms appear to be prominently related to longer DUP. Neuroimaging correlates of DUP have not been clearly outlined: few of the studies considering first-episode patients and DUP showed structural abnormalities. A low proportion of significant associations were found mostly in cerebellum and occipital lobe of patients with longer DUP. Also, evidence of an inverse correlation between cognitive alterations and DUP is not conclusive. DUI and DUP are multidimensional constructs that imply both intrinsic, illness related (e.g. subtle symptoms at onset) and extrinsic factors (e.g. access to mental health services), so that from its study sprouted in the last decades First-Episode Units, aimed at providing secondary prevention in SCZ such as providing a timely diagnosis and treatment to patients experiencing their first psychotic episode. Early intervention seems to ensure a shortened DUP, especially for people presenting with brief limited intermittent psychotic symptoms, and, ultimately, ensure a more favorable prognosis for patients affected by SCZ.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Duration of untreated illness; Duration of untreated psychosis; Early interventions; First-episode; Prediction of outcome; Schizophrenia

Mesh:

Year:  2016        PMID: 27717830     DOI: 10.1016/j.neulet.2016.10.003

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Relationship between duration of untreated prodromal symptoms and symptomatic and functional recovery.

Authors:  TianHong Zhang; LiHua Xu; YingYing Tang; HuiRu Cui; XiaoChen Tang; YanYan Wei; Yan Wang; Qiang Hu; ZhenYing Qian; XiaoHua Liu; ChunBo Li; JiJun Wang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-25       Impact factor: 5.270

3.  Association between depression in chronic phase and future clinical outcome of patients with schizophrenia.

Authors:  Yuto Yamada; Yusuke Yamauchi; Shinji Sakamoto; Masaki Fujiwara; Yuko Okahisa; Soshi Takao; Manabu Takaki; Norihito Yamada
Journal:  Psychopharmacology (Berl)       Date:  2022-02-21       Impact factor: 4.530

4.  Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning.

Authors:  Rigas F Soldatos; Micah Cearns; Mette Ø Nielsen; Costas Kollias; Lida-Alkisti Xenaki; Pentagiotissa Stefanatou; Irene Ralli; Stefanos Dimitrakopoulos; Alex Hatzimanolis; Ioannis Kosteletos; Ilias I Vlachos; Mirjana Selakovic; Stefania Foteli; Nikolaos Nianiakas; Leonidas Mantonakis; Theoni F Triantafyllou; Aggeliki Ntigridaki; Vanessa Ermiliou; Marina Voulgaraki; Evaggelia Psarra; Mikkel E Sørensen; Kirsten B Bojesen; Karen Tangmose; Anne M Sigvard; Karen S Ambrosen; Toni Meritt; Warda Syeda; Birte Y Glenthøj; Nikolaos Koutsouleris; Christos Pantelis; Bjørn H Ebdrup; Nikos Stefanis
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

Review 5.  The Gut Microbiome and Treatment-Resistance in Schizophrenia.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2020-03

6.  First help-seeking attempt before and after psychosis onset: measures of delay and aversive pathways to care.

Authors:  Maria Ferrara; Sinan Guloksuz; Walter S Mathis; Fangyong Li; I-Hsin Lin; Sumaiyah Syed; Keith Gallagher; Jai Shah; Emily Kline; Cenk Tek; Matcheri Keshavan; Vinod H Srihari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-05-04       Impact factor: 4.519

Review 7.  The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies.

Authors:  Chengmin Yang; Jing Tang; Naici Liu; Li Yao; Mengyuan Xu; Hui Sun; Bo Tao; Qiyong Gong; Hengyi Cao; Wenjing Zhang; Su Lui
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

8.  A system biology approach based on metabolic biomarkers and protein-protein interactions for identifying pathways underlying schizophrenia and bipolar disorder.

Authors:  Md Altaf-Ul-Amin; Kazuhisa Hirose; João V Nani; Lucas C Porta; Ljubica Tasic; Shaikh Farhad Hossain; Ming Huang; Naoaki Ono; Mirian A F Hayashi; Shigehiko Kanaya
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

9.  Psychosis-spectrum experiences linked to specific psychotherapy readiness domains among psychiatrically hospitalized adolescents.

Authors:  Elizabeth C Thompson; Anthony Spirito; Jiayin Sperry Saarinen; Jennifer C Wolff
Journal:  Early Interv Psychiatry       Date:  2020-09-21       Impact factor: 2.721

10.  COMMENTS: Future Directions for OnTrackNY and Coordinated Specialty Care for Young People with Recent-Onset Psychosis.

Authors:  Jennifer L Humensky; Ilana Nossel; Iruma Bello; Lisa B Dixon
Journal:  J Ment Health Policy Econ       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.